$43.30
Ultimo aggiornamento: Nov 24, 4:02 PM
Comments
Loading...
Guidance e previsioni
Conmed fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/05/2025 | CNMD | Conmed | FY | 2025 | $4.48 | $4.53 | $4.47 | $1.36B | $1.37B | $1.37B | |
07/30/2025 | CNMD | Conmed | FY | 2025 | $4.40 | $4.55 | $4.41 | $1.36B | $1.38B | $1.36B | |
04/30/2025 | CNMD | Conmed | FY | 2025 | $4.45 | $4.60 | $4.34 | $1.35B | $1.38B | $1.36B | |
02/05/2025 | CNMD | Conmed | FY | 2025 | $4.25 | $4.40 | $4.74 | $1.34B | $1.37B | $1.40B | |
10/30/2024 | CNMD | Conmed | FY | 2024 | $4.00 | $4.05 | $3.99 | $1.30B | $1.30B | $1.31B | |
10/04/2024 | CNMD | Conmed | Q3 | 2024 | $0.98 | $1.00 | $0.99 | $315.00M | $318.00M | $318.67M | |
07/31/2024 | CNMD | Conmed | FY | 2024 | $3.95 | $4.02 | $4.29 | $1.30B | $1.31B | $1.33B | |
04/24/2024 | CNMD | Conmed | FY | 2024 | $4.25 | $4.35 | $4.33 | $1.33B | $1.35B | $1.35B | |
01/31/2024 | CNMD | Conmed | FY | 2024 | $4.30 | $4.40 | $4.40 | $1.34B | $1.36B | $1.36B | |
10/25/2023 | CNMD | Conmed | FY | 2023 | $3.45 | $3.55 | $3.48 | $1.24B | $1.26B | $1.25B | |
07/26/2023 | CNMD | Conmed | FY | 2023 | $3.40 | $3.55 | $3.42 | $1.23B | $1.26B | $1.23B | |
04/26/2023 | CNMD | Conmed | Q2 | 2023 | $0.77 | $0.82 | $0.79 | $300.00M | $310.00M | $301.46M | |
04/26/2023 | CNMD | Conmed | FY | 2023 | $3.30 | $3.50 | $3.32 | $1.21B | $1.25B | $1.19B | |
02/02/2023 | CNMD | Conmed | Q1 | 2023 | $0.58 | $0.63 | $0.61 | $262.00M | $272.00M | $268.73M | |
02/02/2023 | CNMD | Conmed | FY | 2023 | $3.20 | $3.45 | $3.37 | $1.17B | $1.22B | $1.21B | |
11/15/2022 | CNMD | Conmed | FY | 2023 | $3.20 | $3.50 | $3.39 | $1.17B | $1.23B | $1.21B | |
10/26/2022 | CNMD | Conmed | FY | 2022 | $3.21 | $3.28 | $3.28 | $1.10B | $1.11B | $1.11B | |
10/26/2022 | CNMD | Conmed | Q4 | 2022 | $0.98 | $1.05 | $1.06 | $305.00M | $320.00M | $313.65M | |
07/27/2022 | CNMD | Conmed | Q3 | 2022 | $0.78 | $0.84 | $0.92 | $275.00M | $290.00M | $284.96M | |
07/27/2022 | CNMD | Conmed | FY | 2022 | $3.40 | $3.55 | $3.50 | $1.09B | $1.14B | $1.12B | |
05/04/2022 | CNMD | Conmed | FY | 2022 | $3.50 | $3.65 | $3.69 | $1.10B | $1.15B | $1.09B | |
01/26/2022 | CNMD | Conmed | FY | 2022 | $3.60 | $3.85 | $3.74 | $1.07B | $1.13B | $1.11B |
FAQ
Qual è la guidance più recente per Conmed (CNMD)?
Le ultime previsioni per Conmed (CNMD) sono state riportate il novembre 5, 2025 per l'intero anno 2025. L'azienda ha fornito una previsione di utili per azione nell'intervallo da $4.48 a $4.53, rispetto all'EPS stimato di $4.47. Inoltre, Conmed ha previsto ricavi tra $1.37B e $1.37B per il trimestre.
Sfoglia guidance e previsioni su tutte le azioni.